Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Medtronic
Merck
Colorcon
McKesson

Get More Done, Faster

Accurate, objective, and timely intelligence to help you make better decisions

4.3/5 based on G2 reviews

4.4/5 based on Crozdesk reviews

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Solutions designed for all your needs

Reliable primary data + expert analysis. We provide answers for your burning questions

→ See why others have switched

Automated Reports
Stop Wasting Time & Money

How much time are you wasting on repetitive tasks?

DrugPatentWatch can take the load off of your team.

Anticipate Generic Drug Launch
Stop Guessing!

Will a generic version of a drug launch? And when?

Expert analysis based on objective data.

What our Clients Say

❝ I've been using DPW for years and I'm grateful for the responsiveness of the owner, Yali Friedman ❞

❝ I like best … the flexible subscription plans (by module, by month, by year, etc.) ❞

❝ My overall experience with DPW is very positive. The team is generally supportive and their features are growing over time. ❞

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

❝ Knowing when drugs are coming off patent and who to contract with has enabled us to stay ahead fo the curve and align ourselves with the proper vendors. ❞

❝ This is a great service with lots of insightful information. ❞

Drug Profile

Global Biopharmaceutical Business Intelligence

  • Identify and evaluate commercial opportunities
  • Branded and generic drug pipeline forecasting
  • Anticipate future revenue events
  • Identify API and finished drug product suppliers
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track investigational drugs and explore new indications for existing drugs
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Automated Reports

Automated Reports & Custom Dashboards

  • Do more with less staff
  • Take the load off your team
  • Automate processes and focus on growing your business
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Track 505(b)(2) entrants

Monitor biosimilar and 505(b)(2) activity

  • Anticipate 505(b)(2) and biosimilar approvals
  • Track OTC-switches, new formulations, biosimilars, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation